UC San Diego Health researchers surveyed and compared early- and late-stage breast and colorectal cancer diagnoses in patients in pre-pandemic 2019 and in 2020, the first full year of the COVID-19 pandemic, discovering fewer of the former and more of the latter as patients delayed care.
UC San Diego researchers modify remdesivir, creating oral version that can be taken earlier in COVID-19 diagnoses. In cell and animal studies, revised drug proved effective and safe. Click here to view original post… […]
Nanoengineers at the University of California San Diego have developed COVID-19 vaccine candidates that can take the heat. Their key ingredients? Viruses from plants or bacteria.
[…]
The Regents Scholars Research Initiative is a program that pairs first-year or transfer Regents Scholars with faculty members who will provide mentorship and research support for the fall semester (or longer, pe… […]
Copyright © 2022 Biotech Networks, LLC
